Michael St. Andre

Michael St. Andre has extensive work experience in the pharmaceutical industry. Michael is currently employed at Entrada Therapeutics as a Principal Scientist since July 2023. Prior to this, they worked at Pfizer, where they held the position of Principal Scientist until July 2023. Before that, they worked at Pfizer for 13 years from 2008 to 2021. During this time, they held the roles of Senior Scientist from September 2019 to July 2021 and Scientist from August 2008 to September 2019.

Michael St. Andre completed their Bachelor of Science (BS) in Biology from Rensselaer Polytechnic Institute between the years 2000 and 2004. Following this, they pursued a Doctor of Philosophy (PhD) in Biomolecular Pharmacology at Boston University School of Medicine from 2013 to 2021.